Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IFNAR1 | P17181 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | NPY1R | P25929 | 1/20 | 0.41 |
| ▸ | NPY2R | P49146 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RAD52 | P43351 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16581496 | 0.96 | IFNAR1 (0.44) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL40420 | 0.84 | ALDH1A1 (0.38) | IFNAR1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL12079030 | 0.80 | TRPM4 (0.38) | ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL18065342 | 0.78 | IFNAR1 (0.46) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL577858 | 0.77 | IFNAR1 (0.60) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL31167972 | 0.77 | IFNAR1 (0.60) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL30548749 | 0.75 | IFNAR1 (0.58) | IFNAR1ALDH1A1LMNAMAPK1NPY1R | |
| SCHEMBL2423602 | 0.75 | — | — | |
| SCHEMBL11141938 | 0.73 | HAO1 (0.40) | LMNA | |
| SCHEMBL9500435 | 0.73 | HAO1 (0.40) | ALDH1A1LMNAKMT2AMAPTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117683058-A | Organic compound based on borazine as core and organic electroluminescent device comprising same | 江苏三月科技股份有限公司 | 2024-03-12 | — | — | CN | claimed |
| US-20230422607-A1 | AMINE COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-12-28 | — | — | US | claimed |
| WO-2023132694-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2023-07-13 | — | — | WO | claimed |
| WO-2022177288-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2022-08-25 | — | — | WO | claimed |
| CN-114656949-A | Quantum dot-containing material and preparation method thereof, cross-linked material and preparation method thereof, and light-emitting device | 三星显示有限公司 | 2022-06-24 | — | — | CN | claimed |
| CN-114561212-A | Quantum dot-containing material, preparation method thereof, composition and light-emitting device | 三星显示有限公司 | 2022-05-31 | — | — | CN | claimed |
| CN-114203937-A | Arylamine compound, light-emitting device including same, and electronic apparatus including light-emitting device | 三星显示有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-113838987-A | Organic light emitting device | 三星显示有限公司 | 2021-12-24 | — | — | CN | claimed |
| CN-111211247-A | Organic light emitting device | 三星显示有限公司 | 2020-05-29 | — | — | CN | claimed |
| JP-2007532665-A | — | — | 2007-11-15 | — | — | JP | claimed |
| US-5985926-A | VIRICIDES OF AMINE COMPOUNDS AND HYDROCARBONS | CELL THERAPEUTICS, INC. (US) | 1999-11-16 | — | — | US | claimed |
| US-5856331-A | LYSOPHOSPHATIDIC ACYLTRANSFERASE INHIBITOR | CELL THERAPEUTICS, INC. (US) | 1999-01-05 | — | — | US | claimed |
| WO-1998034601-A2 | METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION | CELL THERAPEUTICS, INC. (US) | 1998-08-13 | — | — | WO | claimed |
| EP-0739203-A1 | METHOD FOR TREATING DISEASES MEDIATED BY CELLULAR PROLIFERATION IN RESPONSE TO PDGF, EGF, FGF AND VEGF | CELL THERAPEUTICS, INC. (US) | 1996-10-30 | — | — | EP | claimed |
| EP-0728003-A1 | METHOD FOR PREVENTING TISSUE INJURY FROM HYPOXIA | CELL THERAPEUTICS, INC. (US) | 1996-08-28 | — | — | EP | claimed |
| EP-0676958-A1 | METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION | CELL THERAPEUTICS, INC. (US) | 1995-10-18 | — | — | EP | claimed |
| WO-1995019171-A1 | METHOD FOR TREATING DISEASES MEDIATED BY CELLULAR PROLIFERATION IN RESPONSE TO PDGF, EGF, FGF AND VEGF | CELL THERAPEUTICS, INC. (US) | 1995-07-20 | — | — | WO | claimed |
| WO-1995013075-A1 | METHOD FOR PREVENTING TISSUE INJURY FROM HYPOXIA | CELL THERAPEUTICS, INC. (US) | 1995-05-18 | — | — | WO | claimed |
| WO-1995012396-A1 | METHOD FOR INHIBITING INTRACELLULAR VIRAL REPLICATION | CELL THERAPEUTICS, INC. (US) | 1995-05-11 | — | — | WO | claimed |
| US-4675316-A | FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1987-06-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230422607-A1 | AMINE COMPOUNDS AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | L1CAM, SLC1A2, AOC2 | IFNAR1 1457/4885ALDH1A1 31/4885LMNA 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.